ACC issues

ACC issues decision pathway for postpartum cardiovascular care

A new Expert Consensus Decision Pathway by the American College of Cardiology (ACC) provides recommended strategies for improving postpartum care for individuals with and at risk for short- and long-term cardiovascular disease (CVD).  The clinical document guides postpartum maternal cardiovascular health, recommending comprehensive postpartum cardiovascular care visits; early outpatient follow up for cardiovascular symptom monitoring; effective management of postpartum cardiovascular emergencies; and noncardiovascular aspects of care like lactation, mental health and contraception.  The ...

Prior myocardial infarction linked to faster cognitive decline

A decade-long analysis of more than 20,000 participants in the REGARDS cohort found that prior myocardial infarction (MI) -- including clinically silent MIs detected only by ECG -- was linked to significantly faster rates of cognitive decline over ti...

Bariatric surgery outperforms GLP-1 RAs in lifetime ASCVD risk reduction

In a real-world cohort study of adults with obesity, both metabolic and bariatric surgery and glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy produced similar modest reductions in 10-year atherosclerotic cardiovascular disease (ASCVD) ris...


Sixty Seconds Science


Spotify episodes

Apple podcasts

Google podcasts

Partner

Search:
Date
Filters:
The CAPIte...
25:30

The CAPItello-291 Trial: Final Overall Survival Results of Capivasertib and Fulvestrant in HR+/HER2− Advanced Breast Cancer

Presenter: Hope Rugo
Oncology : Breast Cancer
ESMO BC 2026
Immunother
12:02

Immunotherapy in Early-Stage Breast Cancer - Report from ESMO BC 2026

Presenter: Giampaolo Bianchini
Oncology : Breast Cancer
ESMO BC 2026
Highlights
9:44

Highlights and key takeaways from the 2026 EPA Congress

Presenter: Meryam Schouler-Ocak
Psychiatry
EPA 2026
Therapeuti
7:55

Therapeutic Novelties in the New ACC 2026 Acute Pulmonary Embolism Guideline

Presenter: Geoffrey D. Barnes
Cardiology
ACC 2026
Efficacy a
4:25

Efficacy and Safety of Sotatercept in PH-HFpEF: Results From the Phase 2 CADENCE Trial

Presenter: Mardi Gomberg-Maitland
Cardiology
ACC 2026
The INSIS
8:01

The INSIS Metacohort Vaccine Safety Study: A Paradigm for Clinical and Immune AEFI Profiling

Presenter: Asimenia Angelidou
Internal Medicine
WVCDC 2026
Human Chal
11:07

Human Challenge Models: A New Gold Standard?

Presenter: Stephen Thomas
Internal Medicine
WVCDC 2026
Combining
6:33

Combining Respiratory Vaccines - Balancing Efficacy, Durability and Immunization Schedules

Presenter: Bill Hausdorff
Internal Medicine
WVCDC 2026
Prove it's
3:05

Prove it's safe: Is this the new vaccine policy "norm?"

Presenter: Richard Hughes IV
Internal Medicine
WVCDC 2026
Building a
4:00

Building a Future of Vaccine Trust Through Transparency and Innovation

Presenter: Yurong Fei-Bloom
Internal Medicine
WVCDC 2026
Mavacamten
2:53

Mavacamten in Symptomatic Adolescent Patients With Obstructive HCM: Results From the Phase 3 Scout-HCM Trial

Presenter: Joseph William Rossano
Cardiology
ACC 2026
Pulmonary
13:35

Pulmonary Embolism in 2026: A Case-Based Journey From Diagnosis to Recovery

Presenter: Stanislav Henkin
Cardiology
ACC 2026
Kardinal:
8:56

Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension

Presenter: Luke Laffin
Cardiology
ACC 2026
Meet the E
7:26

Meet the Experts: 2025 High Blood Pressure Guideline

Presenter: Keith C. Ferdinand
Cardiology
ACC 2026
Acute Pulm
6:35

Acute Pulmonary Embolism Guideline 2026

Presenter: Gregory Piazza
Cardiology
ACC 2026
2025 High
3:02

2025 High Blood Pressure Guideline

Presenter: Daniel W. Jones
Cardiology
ACC 2026
Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
The import
11:22

The importance of the anterior interface in eye surgery

Presenter: Marie-José Tassignon
Internal Medicine
Haematolog
17:26

Haematology is at the forefront - interview with EHA President

Presenter: Antonio Almeida
Oncology
Overall Su
13:30

Overall Survival Results of KEYNOTE-564

Presenter: Stefan N. Symeonides
Oncology
General as
1:18

General aspects of the ESH2023 Hypertension Guidelines - What are the major changes?

Presenter: Michel Burnier
Cardiology
How shall
1:23

How shall be treat hypertension and look at cardiac risk factors when we consider proper treatment?

Presenter: Konstantinos Tsioufis
Cardiology
How to tre
1:06

How to treat patients optimally with chronic coronary syndromes in 2023?

Presenter: Luis Henrique Gowdak
Overall Su
20:13

Overall Survival Results of KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma

Presenter: David F. McDermott
Oncology
How novel
1:07

How novel AI model may help physicians distinguish and identify prefibrotic primary myelofibrosis from essential thrombocythemia?

Presenter: Andrew Srisuwananukorn
Hematology
The future
1:10

The future of Multiple Myeloma management

Presenter: Xavier Leleu
Hematology
Benefits o
1:01

Benefits of myeloma regimens in the real world fall well short of trials

Presenter: Alissa Visram
Hematology
The prefer
0:57

The preferred treatment of hypertension with RAAS blockade inhibitors

Presenter: Martin Strauss
Cardiology
What clini
1:16

What clinicians should know about the new ESH guideline regarding hypertension in women?

Presenter: Renata Cifkova
Cardiology
How to man
1:00

How to manage isolated systolic hypertension in the young?

Presenter: Paolo Palatini
Cardiology
Blood pres
1:34

Blood pressure monitoring in general and what we can do to encourage people.

Presenter: Neil Poulter
Cardiology
How to man
1:08

How to manage masked and masked uncontrolled hypertension?

Presenter: Paolo Palatini
Cardiology
ESMO 2023
1:13

ESMO 2023 Scientific Chair's welcome and invitation to next year's ESMO Congress

Presenter: Silke Gillessen
Oncology